
Principle Investigator(s):
Funder: National Institute on Drug Abuse
Project period: 08/01/2017 - 07/31/2019
Grant Type: Research
Further Detail
Abstract Text:

Funder: National Institute on Drug Abuse
Project period: 08/01/2017 - 07/31/2019
Grant Type: Research
Further Detail
Abstract Text:
NIH Director's New Innovator Award (DP2 Clinical Trial Optional)
Application due date: August 17, 2026
NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
Application due date: September 3, 2026
NIH Director's Pioneer Award (DP1 Clinical Trial Optional)
Application due date: September 9, 2026
NIH Director's Early Independence Award (DP5 Clinical Trial Optional)
Application due date: September 10, 2026
PCORI: Addressing Substance Use
Town Hall: August 18, 2026, 12 pm-1 pm
Letter of intent due date: September 9, 2026, 5:00 pm
Letter of intent status notification: October 14, 2026
Application due date: January 12, 2027, 5:00 pm
PCORI: Advancing the Science of Engagement in Research
Town Hall: August 11, 2026, 12 pm-1 pm
Letter of intent due date: September 9, 2026, 5:00 pm
Letter of intent status notification: October 14, 2026
Application due date: January 12, 2027, 5:00 pm
PCORI: Broad Pragmatic Studies
Town Hall: August 13, 2026, 11:30 am-1 pm
Letter of intent due date: September 9, 2026, 5:00 pm
Letter of intent status notification: October 14, 2026
Application due date: January 12, 2027, 5:00 pm
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Application due dates: September 25
Expiration date: September 26, 2028
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
Application due dates: October 21
Expiration date: October 21, 2028
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Application due dates: October 16, February 16, June 16
Expiration date: March 17, 2029
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Application due dates: September 25, January 25, May 25
Expiration date: May 26, 2029
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Application due dates: September 25, January 25, May 25
Expiration date: May 26, 2029
Spatializing Substance Use and Sexual Behaviors of Queer Men and Non-binary Individuals During COVID-19
Bryce Puesta Takenaka, Sitara M Weerakoon, Adam Viera, Frances Griffith, Kaylia Carroll, Erin Nicholson, Sally J Kirklewski, Nathan B Hansen, Trace Kershaw
AIDS and Behavior. 2026 Jun 22. doi: 10.1007/s10461-026-05189-0. Online ahead of print.
Getting Back on the Path to Eliminating HIV in Children
George K Siberry
Journal of the International AIDS Society. 2026 Jun;29 Suppl 1(Suppl 1):e70102. doi: 10.1002/jia2.70102.
Study Design, Methods, and Modeling in Networks to Inform HIV Interventions and Policy in Marginalized Populations
Ashley Buchanan, Claire Pearsall, Stephen Kogut, Jeffrey Bratberg, Joseph Hogan, Samuel R Friedman, Natallia Katenka
Rhode Island Medical Journal. 2026 Jul 1;109(7):36-41.
Copyright © 2026 Yale University. All rights reserved. Privacy policy.
Center for Interdisciplinary Research on AIDS at Yale University
135 College Street, Suite 200, New Haven, CT 06510-2483
Ph: 203-764-4333
CIRA is supported by National Institute of Mental Health Grant No. P30MH062294.
Trace Kershaw, Ph.D., Principal Investigator

